Find Academic Supervisors

• Virus-like particles
• HIV research
• Bioreactors
• +8 more

Francesc Godia Casablancas is a Professor in the Department of Chemical, Biological and Environmental Engineering at Universitat Autònoma de Barcelona. He leads the research group Enginyeria de Bioprocessos i Biocatàlisi Aplicada (ENG4BIO) and is affiliated with the Centre for Space Studies and Research (CEREs). His academic background includes a Ph.D. in Ciències Químiques from Universitat Autònoma de Barcelona (awarded May 21, 1986) and a degree in Ciències Químiques from the same institution (awarded July 10, 1981). His academic career progression at UAB included Becario F.P.I. (1982-1984), Ayudante Prácticas (1984-1987), Ayudante Facultad LRU (1987-1987), Titular interino (1988-1989), and Titular (1989-1993). Research Focus Dr. Godia Casablancas specializes in virus-like particles, HIV research, and bioprocess engineering. His work centers on developing bioprocess technologies for virus-like particle production, particularly for vaccine applications. His research spans chemical, biological, and environmental engineering domains with strong emphasis on applied biocatalysis and bioreactor design. His recent publications demonstrate a consistent focus on HIV-1 based virus-like particles, with applications in vaccine development against SARS-CoV-2 and other pathogens. His work shows strong integration of molecular biology, protein engineering, and bioprocessing techniques to optimize viral vector production and functionality. Scientific Recognition h-index of 34 with 3931 citations according to Scopus 192 research outputs including journal articles, book chapters, and patents 37 research projects with 5 currently active through 2026-2031 ORCID: 0000-0002-4060-9887 Research Leadership Dr. Godia Casablancas serves as Principal Investigator for multiple significant projects including VIRUS LIKE PARTICLES AS MICROCARRIERS OF MOLECULES WITH BIOLOGICAL FUNCTIONALITY (2023-2026), PLATAFORMA DE SUSPENSIÓN CELULAR PARA TERAPIAS BASADAS EN ADENOVIRUS (THERICEL, 2024-2027), and participation in the European Rare Diseases Research Alliance (ERDERA, 2024-2031). He has supervised 54 research projects and maintains extensive collaborations, particularly with L. Cervera Gracia, across virology and bioprocess engineering fields.

Wei XieView profile

Associate Professor

• Interpretable AI
• IoT
• Computer Simulation
• +7 more

Wei Xie is an Associate Professor in the Department of Mechanical and Industrial Engineering at Northeastern University. His research focuses on interpretable AI, IoT, and data-driven stochastic optimization for complex systems in biopharmaceutical manufacturing, smart grids, and healthcare. He holds a PhD from Northwestern University (2014) and has received prestigious awards including the NSF CAREER Award (2025) and the INFORMS Simulation Society Outstanding Publication Award. His work bridges simulation, machine learning, and operations research to address real-world challenges in manufacturing, energy, and healthcare. Education: PhD in Industrial Engineering and Management Sciences from Northwestern University (2014). Research Interests: Interpretable AI and hybrid modeling for bioprocesses Blockchain for supply chain risk management Stochastic optimization in renewable energy systems Data integrity and big data analytics Notable Projects: Principal Investigator for NSF-funded research on mechanism-informed AI for biomanufacturing, and NIIMBL grants on mRNA vaccine potency assessment and stem cell culture monitoring. Awards: 2025 NSF CAREER Award 2023 Constantinos Mavroidis Award INFORMS Simulation Society Award (2023) Advising & Grants: Supervised PhD students in areas like stochastic simulation and biomanufacturing. Secured over $800K in federal and industry grants since 2018. Labs/Teams: Active contributor to Northeastern's Institute for Experiential AI and National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL).

Nikhil NairView profile

Associate Professor

• Synthetic Biology
• Systems Bioengineering
• Protein Engineering
• +3 more

Dr. Nikhil Nair is an Associate Professor in the Department of Chemical and Biological Engineering at Tufts University, USA, and a member of the Graduate Biomedical Sciences Program in Genetics, Molecular and Cellular Biology. He holds a B.S. in Chemical Engineering from Cornell University (2003), an M.S. (2006) and Ph.D. (2010) in Chemical & Biomolecular Engineering from the University of Illinois at Urbana-Champaign. After postdoctoral training at Harvard Medical School, he joined Tufts in 2010. Research Focus: The Nair Lab engineers microbial systems to advance applications in biofuels, biocatalysis, and biomedical therapeutics. Key projects include synthetic biology approaches to reprogram microbial physiology, protein engineering for enhanced biocatalyst performance, and metabolic pathway design for novel product synthesis. Recent initiatives explore cultivated meat media optimization using microbial lysates and engineering bacterial spores for environmental remediation. Key Contributions: Dr. Nair’s work bridges foundational biology and applied engineering. Notable advancements include a semi-synthetic regulon enabling yeast growth on pentoses, engineered lactobacilli for anti-biofilm activity, and machine learning-driven enzyme stability improvements. His lab also pioneered methods to quantify probiotic-mucus interactions and suppress false positives in biosensor-guided evolution. Awards & Recognition: He was named a Senior Member of the National Academy of Inventors (2025) for contributions to engineered biological systems. His research is supported by grants from the NIH, USDA, and industry partnerships. Education & Training: The lab trains Ph.D. students, postdocs, and undergraduates in synthetic biology, metabolic engineering, and systems bioengineering. Current projects span lab-grown meat media development, antimicrobial peptide engineering, and synthetic microbial consortia design. Career Highlights: Over 75 peer-reviewed publications, 5 issued patents, and invited talks at major conferences including the International Metabolic Engineering Conference and Synthetic Biology: Engineering, Evolution & Design (SEED).

Ralf TakorsView profile

Professor

• Metabolic Engineering
• Bioprocess Engineering
• Systems Biology
• +3 more

Ralf Takors is a Professor and Director of the Institute of Biochemical Engineering at the University of Stuttgart. His research focuses on metabolic engineering, systems biology, and bioprocess optimization, particularly in scaling-up microbial and mammalian cell processes to industrial scales. He leads the Takors research team, which integrates biochemical engineering principles with synthetic biology tools to enhance bioproduction efficiency. His academic career includes roles at Evonik Degussa GmbH (2004–2009) and habilitation at Forschungszentrum Jülich (1997–2004). He teaches courses in biochemical engineering, metabolic engineering, and bioreaction engineering. Key awards include acatech membership (2021) and the DECHEMA Young-Professor Award (2001). Research interests span gas fermentation scaling, bioreactor design optimization, and strain engineering. Notable contributions include studies on bubble column fermentations, co-culture systems, and genome-reduced microbial strains for enhanced bioproduction. His work emphasizes translating lab-scale innovations to industrial applications through rigorous modeling and process validation. Publications (2025–2024) highlight advancements in bioprocess engineering, including scaling strategies, metabolic modeling, and novel bioreactor configurations. Teaching engagements span multiple universities and workshops globally, emphasizing systems approaches in biotechnology.

• Bioprocess technology
• Industrial biotechnology
• Medical biotechnology
• +5 more

Peter Satzer is a Senior Lecturer (Privatdozent) at the Institute of Bioprocess Science and Engineering, Department of Biotechnology and Food Science, University of Natural Resources and Life Sciences, Vienna (BOKU). He currently serves as Group Lead for Bioprocessing of Advanced Medicines and is the CO-Founder of p4b GmbH, a company focused on 3D printing for biotechnology. Dr. Satzer completed his PhD in Biomolecular Technology of Proteins (BioToP) from 2011 to 2015, followed by postdoctoral research in Next Biopharmaceutical Downstream Processes from 2016 to 2019. His academic journey began with a Master's program in Biotechnology from 2008 to 2011. Dr. Satzer's research focuses on bioprocess technology , with particular expertise in industrial biotechnology , medical biotechnology , fermentation , circular economy , sustainable technologies , waste prevention , and energy saving . His work bridges the gap between fundamental bioprocess engineering and practical industrial applications, with a strong emphasis on sustainability and process intensification. He is particularly known for his contributions to continuous bioprocessing, viral vector production, and innovative applications of 3D printing in biotechnology. An analysis of Dr. Satzer's recent publications reveals a strong focus on advancing biomanufacturing technologies. His work spans multiple areas including continuous downstream processing, viral vector production systems, 3D printing applications for bioprocessing equipment, and sustainable manufacturing practices. A notable trend is his increasing focus on integrating digital tools and sustainable practices into bioprocess design, with significant contributions to open-source platforms for techno-economic analysis and resource-efficient manufacturing approaches. Dr. Satzer has received the following scientific awards: aws preseed company funding price (2023) Merck Life Science Award in Bioseparations (2015) Dr. Satzer has supervised seven theses, including doctoral and master's level research, focusing on areas such as virus-like particle vaccines, continuous bioprocessing, and advanced monitoring techniques. He is currently involved in two significant research projects: "Sustainable chromatography by design and rational sustainable buffer selection" (2024-2025) and the "Christian Doppler Laboratory for Knowledge-based Production of Gene Therapy Vectors" (2023-2029), where he contributes his expertise in bioprocess engineering for advanced therapeutic manufacturing. As Group Lead for Bioprocessing of Advanced Medicines, Dr. Satzer oversees research activities focused on next-generation biopharmaceutical manufacturing, particularly for advanced therapies including viral vectors and virus-like particles. His team works at the intersection of traditional bioprocessing and emerging technologies, with a strong emphasis on sustainability and process innovation.

Yi ZhangView profile

Assistant Professor

• Food Science
• Bioprocessing
• Enzymology
• +4 more

Yi Zhang is an Assistant Professor in the Department of Food Science at Pennsylvania State University, specializing in interdisciplinary research at the intersection of bioprocessing, food chemistry, and sustainable materials. Their work focuses on transforming food waste into functional bioresources through enzymatic technologies. Key Research Themes : Food enzymes (transglutaminase, trypsin), bioprocess optimization, allergen mitigation, and circular bioeconomy applications Recent Projects : Biomanufacturing platforms for dairy waste conversion, plant miRNA stability in digestion, and biodegradable packaging from plant/animal proteins Yi Zhang's publications from 2023-2025 demonstrate expertise in protein modification, gelatin characterization, and sustainable food systems. They collaborate extensively on projects involving enzymatic hydrolysis, cross-linking technologies, and functional food development. Current affiliations include the Elsevier Pure Profile and IEE Research Themes in Health and the Environment. Their research integrates physicochemical analysis with practical applications in food packaging, allergen reduction, and bioplastic development.

• Antibiotic Resistance
• Industrial Biotechnology
• Omic Technologies
• +2 more

Fatma Gizem AVCI is an Assistant Professor at Uskudar University, Department of Bioengineering, Turkey. Her research focuses on antibiotic resistance, protein engineering, and metabolic engineering, aligning with industrial biotechnology and omic technologies. She has extensive international academic experience, including a FEMS Research Fellowship at CNRS, Lyon, and Erasmus Exchange Programme collaboration at Ghent University. B.Sc. and M.Sc. in Bioengineering, Ege University Ph.D. in Bioengineering, Marmara University (2018) Her research explores: Antivirulence strategies targeting bacterial pathogenesis Industrial biotechnology for sustainable biomanufacturing Omic technologies to study microbial stress responses Protein engineering for antimicrobial solutions Metabolic engineering of microbial pathways Scientific awards include the FEMS Research Fellowship. She has supervised graduate theses on antivirulence agents and serves on multiple administrative committees, including the Strategy Development Coordination Commission at Uskudar University.

Robert FlassigView profile

Research Professor

• Technical Energy Efficiency
• Process Systems Engineering
• Machine Learning Applications
• +6 more

Prof. Dr.-Ing. Robert Flassig is a Research Professor for Technical Energy Efficiency at the Brandenburg University of Applied Sciences , focusing on interdisciplinary research at the intersection of energy systems, process engineering, and computational methods. With extensive collaborations across institutions like the Max Planck Institute and TU Berlin, his work emphasizes methodological innovation in mathematical modeling, machine learning, and optimization for industrial applications. Research Highlights: Technical Energy Efficiency and Resource Management Machine Learning for Biological and Engineering Systems Reactor Network Synthesis via Flux Analysis Stochastic Modeling of Actomyosin Dynamics Scientific Recognition: 2017 DECHEMA Young Talent Award 2013 Sbv Improver 1st Place (Nature) 2009 DREAM 4 In Silico Challenge 3rd Place Key Collaborations: Rolls-Royce Deutschland, Max Planck Institute, TU Berlin, and Fraunhofer IPK. His recent projects ( VITVI , AutoBlisk ) integrate AI for virtual engine development and multidisciplinary design optimization, securing 1.5M€ in research funding.

Luke J MortensenView profile

Associate Professor

• Regenerative Medicine
• Biomedical Engineering
• Optical Physics
• +5 more

Luke J Mortensen is an Associate Professor of Regenerative Medicine and Engineering in the Department of Animal and Dairy Science at the University of Georgia, with a joint appointment in the School of Chemical, Materials, and Biomedical Engineering. His research bridges engineering, regenerative medicine, and imaging technologies with a focus on bone and muscle regeneration. Dr. Mortensen's educational background includes: Ph.D. in Biomedical Engineering from the University of Rochester (2011) M.S. in Biomedical Engineering from the University of Rochester (2006) B.S. in Bioengineering from the University of Toledo (2003) Dr. Mortensen's research primarily focuses on regenerative medicine in bone and muscle. His long-term goals include creating next-generation super-resolution 2 and 3 photon microscopes for imaging cell organelles through opaque bone, and leveraging key imaging and lipid metabolite features associated with mesenchymal stem cell (MSC) therapeutic potency to biomanufacture efficacious cell therapies. His work integrates advanced imaging techniques with lipidomics to understand and enhance stem cell therapies for musculoskeletal conditions. Analysis of Dr. Mortensen's recent publications reveals a strong focus on MSC potency metrics, advanced imaging through bone tissue, and lipid-mediated regenerative processes. His work spans multiple disciplines including biomedical engineering, optical physics, and regenerative medicine, with particular emphasis on developing novel imaging approaches for studying cellular processes in challenging environments like bone tissue. Dr. Mortensen has secured significant research funding from diverse sources including the National Institutes of Health, National Science Foundation, Department of Defense, and private foundations. His sponsored projects cover areas such as bone microfracture repair, MSC potency assessment, and advanced imaging technologies. Dr. Mortensen leads a research team focused on regenerative medicine and engineering, working at the intersection of imaging technology development and therapeutic applications for musculoskeletal disorders. His lab combines expertise in microscopy, lipidomics, and stem cell biology to address challenges in regenerative medicine.

• Biochemical Engineering
• Bioprocess Engineering
• Fermentation Technology
• +5 more

Prof. Dr.-Ing. Jørgen Barsett is a University Professor leading the Chair of Biochemical Engineering at the Faculty of Mechanical Engineering, RWTH Aachen University since April 2023. His research focuses on characterizing processes in bioreactors of all scales—from microtiter plates to fermenters—with emphasis on developing and applying innovative methods for online process analysis and control. Key research areas include syngas fermentation and the production of sustainable products through fermentation. His research interests span across multiple areas of biochemical engineering: Bioprocess monitoring and control Online process analysis Scale-up of bioprocesses from microtiter plates to industrial fermenters Syngas fermentation technologies Sustainable production of biochemicals Cell and gene therapy manufacturing Prof. Barsett's recent publications demonstrate a strong focus on advanced bioprocess monitoring, characterization, and optimization across various microbial systems. His research spans from fundamental microbial metabolism studies to applied bioprocess engineering solutions for pharmaceutical and industrial applications. The work covers diverse organisms including Komagataella phaffii (yeast), Vibrio natriegens (bacteria), CHO cells (mammalian), Ustilago maydis (fungus), and Corynebacterium glutamicum (bacteria), addressing challenges in oxygen transfer, carbon source utilization, and product formation. His scientific contributions include: Development of novel multiparameter sensors for shake flask cultivations Advanced methods for online monitoring of bioprocess parameters Studies on gas fermentation and syngas utilization Optimization of microbial lipid production Scale-up strategies from microtiter plates to industrial bioreactors Prof. Barsett actively supervises students and collaborates with industry partners on bioprocess development projects. His laboratory focuses on bridging the gap between fundamental biochemical research and industrial application, with particular emphasis on developing sustainable bioprocesses and improving biomanufacturing efficiency.

• Bioprocess Engineering
• Biopharmaceutical Production
• Fermentation Technology
• +3 more

Prof. Jørgen Magnus serves as Chair of Bioprocess Engineering at RWTH Aachen University, Germany, with his primary affiliation in the AVT (Aachener Verfahrenstechnik) department under the university's Molecular Science & Engineering (MSE) profile area. He holds a Professor rank and maintains active duties as evidenced by his office location in Research Building NGP2 (Room A-307, Forckenbeckstraße 51, Aachen) and direct contact channels including email jorgen.magnus@avt.rwth-aachen.de. His research program centers on advancing bioprocess engineering through three interconnected domains: biopharmaceutical manufacturing (viral vectors, CHO cell cultures), fermentation innovation (gas fermentations, microbial strain optimization), and process analytics (real-time monitoring, scale-up methodologies). Key specialties include adeno-associated virus (AAV) production, metabolic engineering of hosts like Vibrio natriegens and Komagataella phaffii , and development of novel sensors for dissolved oxygen, biomass, and metabolite tracking across cultivation systems from microtiter plates to industrial bioreactors. Analysis of his 15 most recent publications (2024-2025) reveals consistent emphasis on solving industry-critical bottlenecks in biomanufacturing. A dominant trend involves bridging scale gaps —demonstrated in studies translating microtiter plate data to stirred-tank reactors—and stress mitigation in cell cultures (e.g., hydromechanical stress in CHO cells). His work increasingly integrates renewable feedstocks (e.g., syngas, molasses) with real-time analytics to optimize carbon utilization and product yields, reflecting industry shifts toward sustainable, data-driven bioprocessing.

Jesús Lavado GarcíaView profile

Researcher

• Recombinant Adeno-associated Virus (rAAV) Production
• Virus-Like Particles (VLPs) Production
• Bioprocess Engineering
• +3 more

Jesús Lavado García serves as Postdoctoral Researcher and Co-Principal Investigator at the Novo Nordisk Foundation Center for Biosustainability (DTU Biosustain), Technical University of Denmark. His research focuses on advancing bioprocess engineering for viral vector manufacturing, particularly recombinant adeno-associated viruses (rAAVs) and virus-like particles (VLPs), with direct applications in gene therapy and vaccine development. His core research areas include: Overcoming the cell density effect in mammalian cell cultures Optimizing full-to-empty particle ratios in rAAV production Engineering heparan sulfate proteoglycan interactions for enhanced transfection Metabolic pathway modulation for increased vector yields Statistical design of experiments for bioprocess optimization Glycobiology applications in viral vector manufacturing Analysis of his 2022-2025 publications reveals concentrated innovation in rAAV/VLP process development, with emphasis on resolving production bottlenecks through cell engineering and bioprocess design. His work demonstrates particular expertise in leveraging DNA damage response pathways, extracellular vesicle dynamics, and metabolic engineering to enhance vector titers while maintaining quality attributes. Scientific awards: No awards identified in source materials. Dr. Lavado García actively mentors PhD candidates M. Rahimi (cell density effect engineering) and D. C. Tatjer (CHO-based rAAV processes). He serves as Principal Investigator for the Novo Nordisk Foundation-funded HEDGE-A project (2023-2026) targeting high-density rAAV manufacturing, and as Co-PI on multiple grants addressing viral vector production challenges through mammalian cell engineering approaches. He leads the Quantitative Modeling of Cell Metabolism group at DTU Biosustain, collaborating with European research networks to develop scalable platforms for next-generation gene therapy vectors, with current work focusing on translation of lab-scale optimizations to industrial biomanufacturing.

• Algal Biotechnology
• Bioenergy
• Genetic Engineering
• +5 more

Dr. Thomas Baier is a researcher at the Faculty of Biology , University of Bielefeld , affiliated with the Center for Biotechnology (CeBiTec) and the Algal Biotechnology and Bioenergy working group. His work focuses on harnessing microalgae for sustainable biotechnological applications. Email: Thomas.Baier@uni-bielefeld.de Office: UHG G2-152 Dr. Baier’s research spans algal genetic engineering , metabolic pathway optimization , and bioenergy production , with a particular emphasis on Chlamydomonas reinhardtii as a model organism. His publications highlight advancements in CRISPR/Cas9 gene editing , recombinant protein expression , and sustainable chemical production using phototrophic systems. Recent publications reveal a focus on terpenoid synthesis , carotenoid accumulation , and stress-tolerant algal strains , aligning with Bielefeld University’s strategic research on interdisciplinary biotechnology applications. His work integrates molecular biology, synthetic biology, and industrial bioproduction frameworks.

• Human Health Engineering
• Wearable Technology
• Precision Livestock Farming
• +3 more

Jean-Marie Aerts is a full professor and department chair at the Department of Biosystems within the Faculty of Bioscience Engineering at KU Leuven . He serves as chairman of the Leuven Center for Medical Technology and division head of Bio-Environmental Control and BioAsyst Division . Active member of multiple institutes including DigiSoc – KU Leuven Institute for Digital Society , iSi Health , and Leuven One Health . Head of M3-BIORES research group Chair of Departmental Council for Biosystems Researcher at Animal and Human Health Engineering division His research focuses on Human Health Engineering , with recent projects like WeCARE (wearable technology for childhood cancer care), StressTRACS (stress tracking with wearables), and Precision Biomanufacturing of Joint Implants . Publications span biomedical engineering, movement disorders, and sports performance optimization. Recent article trends show emphasis on machine learning for movement analysis , wearable sensor validation , and cross-sector health technology applications in Parkinson's disease, cerebral palsy, and athlete monitoring.

• Developmental Biology
• Stem Cell Research
• Tissue Engineering
• +3 more

Dr. Nurullah Aydoğdu is an academic researcher affiliated with Yeditepe University, Faculty of Engineering, specializing in Genetics and Bioengineering. His work spans developmental biology, stem cell research, and tissue engineering. Institution: Yeditepe University School: Faculty of Engineering Department: Genetics and Bioengineering His research focuses on: Signaling pathways in organ development (e.g., FGFR2, SHH-BMP4, WNT) Mesenchymal stem cell applications and differentiation GMP-compliant protocols for tissue processing and cellular product preparation Molecular mechanisms in ureter and tooth development Mesothelial cell dynamics in lung and heart formation Recent publications emphasize translational approaches combining developmental biology and biomanufacturing standards. He has contributed to protocols for stem cell isolation from dental and umbilical sources and explored melatonin's role in cellular differentiation. No scientific awards or student advisement details are publicly listed in the provided data.